RANI: Rani Therapeutics Holdings Company Short-Term Debt

Symbol and logo of brand ranitherapeutics.com (RANI)

High engineering costs for robotic capsules are blocking operating leverage for Rani Therapeutics (RANI) until the FDA verdict. Short-term debt dynamics demonstrate a local trend where the parameter value equals 0.00. The business maintains stability through its US base and support from market leaders. Strategic alliances enable the replacement of injections with pills, creating treatment synergy through the integration of biologics.

RANI (ranitherapeutics.com) Company Short-Term Debts history from 07/04/2022 to 10/31/2026

Analytical breakdowns and data insights for company Rani Therapeutics Holdings (RANI)

- current quotes and average value forecast:
Price Chart Rani Therapeutics Inc|RANI - Fair Value Consensus
- market capitalization information:
Market Value Rani Therapeutics Holdings, Inc.|RANI - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Rani Therapeutics|RANI - Book Capitalization|Market Cap to Net Assets Ratio ranitherapeutics.com|RANI - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Rani Therapeutics|RANI - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Rani Therapeutics Inc|RANI - Company Cumulative Indebtedness|Debts to Book Capitalization Rani Therapeutics Holdings, Inc.|RANI - Company Long-Term Loans and Borrowings|Company Short-Term Debts Rani Therapeutics|Quick Liquidity ranitherapeutics.com
- net income and valuation multiples indicators:
RANI - Final Profit
Summary company analytics:ranitherapeutics.com (RANI)
Mass-produced product of Rani Therapeutics

This indicator aggregates all liabilities with a maturity horizon of up to one year, determining the business's need for urgent refinancing and its sensitivity to the cost of borrowed capital. The stable workforce of biomedical engineers at Rani Therapeutics (RANI) reduces operational risks, allowing the efficiency of liquidity management during the scaling of clinical operations to be assessed via the book value of short-term debt.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|AMPH: Company Short-Term Debts|Pacira Pharmaceuticals - Company Short-Term Loans and Borrowings|SPRY (ARS Pharma) - Company Short-Term Debts|Short-Term Debt Theravance Corp TBPH|Company Short-Term Debt Aquestive Therapeutics (AQST)|SCPH (scpharmaceuticals.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Tectonic Therapeutic TECX|Company Short-Term Loans and Borrowings TNXP|SXT China - Company Short-Term Debts|EPRX - Company Short-Term Debts|BioHarvest Sciences (BHST) - Company Short-Term Debt|Company Short-Term Indebtedness EXOZ|ORMP (Oramed) - Company Short-Term Debts|Entera Bio Corp (ENTX) - Short-Term Debt Volume|Company Current Liabilities HYFT (MindWalk)|ABVC (ABVC BioPharma, Inc) - Company Short-Term Loans and Borrowings|Cumberland Pharmaceuticals - Company Current Liabilities|Amount of Current Liabilities QNTM (quantumbiopharma.com)|FibroGen - Company Short-Term Debts|Company Short-Term Loans and Borrowings TELO (Telomir Pharmaceuticals Inc)|SNYR: Company Short-Term Debts|Short-Term Debt Rallybio (RLYB)|Company Short-Term Debt Lexaria Bioscience Corp|PULM: Company Short-Term Loans and Borrowings|Company Short-Term Debts PTHL|Company Short-Term Debts aptorumgroup.com (APM)|Company Short-Term Debt Lyra Therapeutics, Inc LYRA|IBO (impactbiomedinc.com) - Current Liabilities|TNF Pharma - Company Short-Term Debts|Short-Term Debt cbdMD, Inc.|PRFX (PainReform) - Company Current Liabilities|Altamira Therapeutics Ltd. (CYTO) - Company Short-Term Debts|Company Current Liabilities LIPO|OPTN (OptiNose Corp) - Amount of Current Liabilities|Company Short-Term Debts PIRS|Short-Term Debt Volume procapsgroup.com|Company Short-Term Debts PTPI (Petros Pharmaceuticals, Inc.)|QLI - Company Current Liabilities|SLRN - Company Short-Term Debt|Short-Term Debt Volume TFF Pharmaceuticals, Inc TFFP